Pharmaxis Ltd (AU:SNT) has released an update.
Syntara Limited has announced Tim Luscombe as their new CFO, effective from August 31, 2024, succeeding the retiring David McGarvey, who served for over 20 years. McGarvey will continue as Company Secretary, aiding in the finalization of the sale of the mannitol business unit. Luscombe, with over a decade of financial expertise, joins from Bio101 Financial Advisory, bringing substantial experience from his work with various companies in the healthcare sector.
For further insights into AU:SNT stock, check out TipRanks’ Stock Analysis page.
